Market Research Report
United States Cancer Biomarker Market Opportunities, 2011 - 2021
|Published by||Pharmaion||Product code||354418|
|Published||Content info||117 Pages
Delivery time: 1-2 business days
|United States Cancer Biomarker Market Opportunities, 2011 - 2021|
|Published: March 15, 2016||Content info: 117 Pages||
As per the American Cancer Society estimates, the number of cancer cases in the United States is estimated to have stood at 1,658,370 in 2015. With growing incidence rate of cancer in the country, the demand for cancer biomarker for better diagnosis is also increasing at a robust pace. In the US, growing consumption of alcohol and high smoking prevalence coupled with poor dietary habits and sedentary lifestyle of the citizens is increasing cancer risk among the country's population. Moreover, increasing government funding for cancer biomarker research, coupled with growing use of biomarkers in drug discovery development and clinical trials is further anticipated to fuel cancer biomarker market in the US over the next five years.
“United States Cancer Biomarker Market Opportunities, 2011 - 2021” report studies the market size and share of various segments and sub-segments of the cancer biomarker market in the United States during the period 2011 - 2021. In the study, the market has been categorized into five broader segments that include Immunoassay, Omics Technology, Cytogenetic Technology, Imaging Technology and Bioinformatics.
The market dynamics section of the report elaborates the factors that are driving the market as well as the challenges inhibiting growth. The research study also includes insights of the key market trends, a detailed analysis of the changing competitive landscape, and revenue forecasts for each segment and sub-segment.
All this information is provided to assist the established market players and new entrants in taking their strategic decisions, thereby aiding them in strengthening their market position in a highly competitive cancer biomarker market in the United States.
“United States Cancer Biomarker Market Opportunities, 2011 - 2021” report elaborates the following aspects of cancer biomarker market in the United States:
The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with cancer biomarker manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.